Literature DB >> 15490332

Inhibition of matrix metalloproteinase-2 and -9 activities by selected flavonoids.

Christina Ende1, Rolf Gebhardt.   

Abstract

Matrix metalloproteinases (MMPs) play an important role in physiological and pathological matrix degradation. Here, we report that flavonoids, at physiologically relevant concentrations, inhibit two members of this enzyme family, namely MMP-2 and -9. Eight flavonoids with increasing number of hydroxy groups and other modifications were compared for their capacity to inhibit recombinant catalytic domains of these proteases. EC50 values ranged from 59 and 70 microM (primuletin/5-hydroxyflavone) to 9 and 4 microM (luteolin 7- O-glucoside) for MMP-2 and -9, respectively. Interestingly, the latter glucoside was an equal (MMP-2) or even stronger (MMP-9) inhibitor than its aglycone, luteolin. For luteolin, one of the strongest flavonoids tested, kinetic analysis revealed a non-competitive type of inhibition. Our results add a novel function to the long list of biological effects of these ubiquitous plant constituents that may contribute to and enhance their modulating influence on extracellular matrix degradation and remodelling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15490332     DOI: 10.1055/s-2004-832630

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  16 in total

1.  Multiple receptor-ligand based pharmacophore modeling and molecular docking to screen the selective inhibitors of matrix metalloproteinase-9 from natural products.

Authors:  Qi Gao; Yijun Wang; Jiaying Hou; Qizheng Yao; Ji Zhang
Journal:  J Comput Aided Mol Des       Date:  2017-06-16       Impact factor: 3.686

2.  The nutraceutical flavonoid luteolin inhibits ADAMTS-4 and ADAMTS-5 aggrecanase activities.

Authors:  Angela Moncada-Pazos; Alvaro J Obaya; Cristina G Viloria; Carlos López-Otín; Santiago Cal
Journal:  J Mol Med (Berl)       Date:  2011-03-02       Impact factor: 4.599

3.  Screening candidate genes related to tenderness trait in Qinchuan cattle by genome array.

Authors:  YingYing Zhang; LinSen Zan; HongBao Wang
Journal:  Mol Biol Rep       Date:  2010-09-17       Impact factor: 2.316

Review 4.  Luteolin, a flavonoid with potential for cancer prevention and therapy.

Authors:  Yong Lin; Ranxin Shi; Xia Wang; Han-Ming Shen
Journal:  Curr Cancer Drug Targets       Date:  2008-11       Impact factor: 3.428

5.  Effects of Luteolin on Liver, Kidney and Brain in Pentylentetrazol-Induced Seizures: Involvement of Metalloproteinases and NOS Activities.

Authors:  Hüsniye Birman; Kadriye Akgün Dar; Ayşegül Kapucu; Samet Acar; Gülay Uzüm
Journal:  Balkan Med J       Date:  2012-06-01       Impact factor: 2.021

6.  Analysis of flavonoid-based pharmacophores that inhibit aggrecanases (ADAMTS-4 and ADAMTS-5) and matrix metalloproteinases through the use of topologically constrained peptide substrates.

Authors:  Mare Cudic; Gayle D Burstein; Gregg B Fields; Janelle Lauer-Fields
Journal:  Chem Biol Drug Des       Date:  2009-09-28       Impact factor: 2.817

7.  Immunomodulatory responses of peripheral blood mononuclear cells from multiple sclerosis patients upon in vitro incubation with the flavonoid luteolin: additive effects of IFN-beta.

Authors:  Zohara Sternberg; Kailash Chadha; Alicia Lieberman; Allison Drake; David Hojnacki; Bianca Weinstock-Guttman; Frederick Munschauer
Journal:  J Neuroinflammation       Date:  2009-10-13       Impact factor: 8.322

8.  Inhibition of angiotensin-converting enzyme activity by flavonoids: structure-activity relationship studies.

Authors:  Ligia Guerrero; Julián Castillo; Mar Quiñones; Santiago Garcia-Vallvé; Lluis Arola; Gerard Pujadas; Begoña Muguerza
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

9.  Compounds isolated from Ageratum houstonianum inhibit the activity of matrix metalloproteinases (MMP-2 and MMP-9): An oncoinformatics study.

Authors:  Anupriya Verma; Syed Mohd Danish Rizvi; Sibhghatulla Shaikh; Mohd Afaque Ansari; Shazi Shakil; Fauzia Ghazal; Mohd Haris Siddiqui; Mohd Haneef; Ajijur Rehman
Journal:  Pharmacogn Mag       Date:  2014-01       Impact factor: 1.085

10.  Inhibition of MMP-2 and MMP-9 Activities by Limonium tetragonum Extract.

Authors:  Min-Joo Bae; Fatih Karadeniz; Seul-Gi Lee; Youngwan Seo; Chang-Suk Kong
Journal:  Prev Nutr Food Sci       Date:  2016-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.